Dr. Zach Adelman's lab at Texas A&M Agrilife Research focuses on innovative genetic engineering strategies to control mosquito populations that transmit diseases like dengue, yellow fever, and chikungunya. The lab explores how gene editing tools like CRISPR can be used to insert or remove genes from mosquitoes, improving efforts to develop safer and more effective mosquito control methods. Their research has the potential to significantly impact public health by making gene drive technologies more reliable and manageable.

Dr. Julian G. Hurdle's lab focuses on understanding the increasing resistance of Clostridium difficile to antibiotics, particularly vancomycin. Their research aims to uncover the genetic changes in these bacteria that lead to treatment failures in patients. The lab uses clinical studies and genetic analyses to improve treatment strategies and ultimately contribute to better health outcomes for patients suffering from C. difficile infections.

Dr. Ivan Rusyn's lab at Texas A&M focuses on improving how we assess the safety of chemicals without relying on animal testing. Their work involves creating advanced laboratory models and computer simulations, which can predict the effects of chemicals more accurately. By developing these new methodologies, the lab aims to enhance regulatory decision-making and promote public health.

Dr. Deborah Bell-Pedersen's lab at Texas A&M University focuses on understanding how the circadian clock affects the production of proteins within cells. They study the complex mechanisms that control when and how proteins are made, particularly through a model organism called Neurospora crassa. Their research aims to reveal how these daily rhythms in protein synthesis impact health, metabolism, and drug effectiveness, potentially leading to better treatments for various diseases.

In Dr. Stephen H. Safe's lab at Texas A&M University, researchers focus on developing new treatments for colorectal cancer. They study a specific receptor, NR4A1, which is found in high levels in colon cancer patients and is linked to tumor growth and immune system suppression. By using innovative compounds known as CDIMs, the team aims to create drugs that can both fight cancer and help improve the immune response against tumors.

Dr. Doodipala Samba Reddy's lab focuses on developing innovative treatments to counteract the harmful effects of nerve agents, particularly in the context of seizure management and brain protection. The primary research involves creating new hydrophilic neurosteroids that can effectively treat severe seizures that do not respond to current medications like midazolam. This research is particularly relevant for military and civilian safety during chemical warfare scenarios.

Dr. Michael C. Golding's lab focuses on understanding how paternal alcohol use can influence the health and development of offspring. Specifically, they explore how alcohol consumption by fathers can lead to epigenetic changes that affect mitochondrial function and contribute to fetal alcohol spectrum disorders (FASDs). By studying these changes in transgenic mouse models, the lab aims to uncover the genetic and biological mechanisms behind these effects and how they can impact long-term health outcomes for children.

Dr. Weston W. Porter's lab at Texas A&M is focused on understanding how biological clocks affect various cellular processes, particularly in the mammary gland. The research explores how disruptions to circadian rhythms can lead to significant health issues, including metabolic disorders and cancer. By investigating the roles of specific factors like PER2, the lab aims to uncover the molecular mechanisms that underlie cell differentiation and homeostasis.

Dr. Alex C Keene's lab at Texas A&M University focuses on understanding the genetics of sleep regulation and its implications for sleep disorders like insomnia. The research combines genetic analysis, animal models, and behavioral studies to identify how specific genes and molecular pathways affect sleep patterns in humans and model organisms. The ultimate goal is to elucidate the biological mechanisms behind sleep-related genetic variations, which could lead to better diagnosis and treatment for sleep disorders.

Dr. Farida Sohrabji's lab at Texas A&M focuses on understanding how stroke affects cognitive impairment, especially in aging female rats. The research explores the role of hormones and microRNAs in stroke recovery and looks at how gut health may influence brain outcomes. Their work aims to develop new therapeutic approaches to improve recovery from stroke, especially for women who are more affected by these conditions.

Dr. Jiang Chang's lab focuses on understanding heart failure, particularly the metabolism of heart cells and how energy supply affects heart function. They are investigating a system called metabolic resuscitation, which could potentially be manipulated to improve treatments for heart failure. By using experimental approaches and animal models, the lab aims to identify new therapeutic strategies and biomarkers for heart failure management.

Dr. Aref Arzan Zarin's lab at Texas A&M University studies how the nervous system can adapt after injury, particularly using the fruit fly as a model organism. The research focuses on understanding how different types of neurons and supporting cells, like glia, can restructure their connections in response to neuron loss, which is crucial for recovery from injuries like stroke and spinal cord damage. By uncovering these mechanisms in fruit flies, the lab aims to inform potential therapies for similar issues in mammals.